Vectura sees strong H1 cash position guardian.co.uk, UK - 7 hours ago It pointed out that Novartis had confirmed 2011 as the year that it will request regulatory approval for its COPD drugs NVA237 and QVA149. ... Vectura sees strong H1 cash position Reuters STOCKS NEWS EUROPE-Vectura rises on update; Teathers says "buy" Reuters UK all 8 news articles |
No comments yet.
RSS feed for comments on this post. TrackBack URI
Sorry, the comment form is closed at this time.
Vectura sees strong H1 cash position guardian.co.uk, UK - 7 hours ago It pointed out that Novartis had confirmed 2011 as the year that it will request regulatory approval for its COPD drugs NVA237 and QVA149. ... Vectura sees strong H1 cash position Reuters STOCKS NEWS EUROPE-Vectura rises on update; Teathers says "buy" Reuters UK all 8 news articles |
No comments yet.
RSS feed for comments on this post. TrackBack URI
Sorry, the comment form is closed at this time.
Vectura sees strong H1 cash position guardian.co.uk, UK - 7 hours ago It pointed out that Novartis had confirmed 2011 as the year that it will request regulatory approval for its COPD drugs NVA237 and QVA149. ... Vectura sees strong H1 cash position Reuters STOCKS NEWS EUROPE-Vectura rises on update; Teathers says "buy" Reuters UK all 8 news articles |
No comments yet.
RSS feed for comments on this post. TrackBack URI
Sorry, the comment form is closed at this time.
Vectura sees strong H1 cash position guardian.co.uk, UK - 7 hours ago It pointed out that Novartis had confirmed 2011 as the year that it will request regulatory approval for its COPD drugs NVA237 and QVA149. ... Vectura sees strong H1 cash position Reuters STOCKS NEWS EUROPE-Vectura rises on update; Teathers says "buy" Reuters UK all 8 news articles |
No comments yet.
RSS feed for comments on this post. TrackBack URI
Sorry, the comment form is closed at this time.
Vectura sees strong H1 cash position guardian.co.uk, UK - 7 hours ago It pointed out that Novartis had confirmed 2011 as the year that it will request regulatory approval for its COPD drugs NVA237 and QVA149. ... Vectura sees strong H1 cash position Reuters STOCKS NEWS EUROPE-Vectura rises on update; Teathers says "buy" Reuters UK all 8 news articles |
No comments yet.
RSS feed for comments on this post. TrackBack URI
Sorry, the comment form is closed at this time.
Vectura sees strong H1 cash position guardian.co.uk, UK - 7 hours ago It pointed out that Novartis had confirmed 2011 as the year that it will request regulatory approval for its COPD drugs NVA237 and QVA149. ... Vectura sees strong H1 cash position Reuters STOCKS NEWS EUROPE-Vectura rises on update; Teathers says "buy" Reuters UK all 8 news articles |
No comments yet.
RSS feed for comments on this post. TrackBack URI
Sorry, the comment form is closed at this time.